Literature DB >> 17610578

Alpha-synuclein involvement in hippocampal synaptic plasticity: role of NO, cGMP, cGK and CaMKII.

Shumin Liu1, Mauro Fa, Ipe Ninan, Fabrizio Trinchese, William Dauer, Ottavio Arancio.   

Abstract

Synaptic plasticity involves a series of coordinate changes occurring both pre- and postsynaptically, of which alpha-synuclein is an integral part. We have investigated on mouse primary hippocampal neurons in culture whether redistribution of alpha-synuclein during plasticity involves retrograde signaling activation through nitric oxide (NO), cGMP, cGMP-dependent protein kinase (cGK) and calmodulin-dependent protein kinase II. We have found that deletion of the alpha-synuclein gene blocks both the long-lasting enhancement of evoked and miniature transmitter release and the increase in the number of functional presynaptic boutons evoked through the NO donor, DEA/NO, and the cGMP analog, 8-Br-cGMP. In agreement with these findings both DEA/NO and 8-Br-cGMP were capable of producing a long-lasting increase in number of clusters for alpha-synuclein through activation of soluble guanylyl cyclase, cGK and calcium/calmodulin-dependent protein kinase IIalpha. Thus, our results suggest that NO, cGMP, GMP-dependent protein kinase and calmodulin-dependent protein kinase II play a key role in the redistribution of alpha-synuclein during plasticity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17610578     DOI: 10.1111/j.1460-9568.2007.05569.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  12 in total

1.  Common key-signals in learning and neurodegeneration: focus on excito-amino acids, beta-amyloid peptides and alpha-synuclein.

Authors:  L F Agnati; G Leo; S Genedani; L Piron; A Rivera; D Guidolin; K Fuxe
Journal:  J Neural Transm (Vienna)       Date:  2008-11-19       Impact factor: 3.575

2.  Mitochondrial and Cell Death Mechanisms in Neurodegenerative Diseases.

Authors:  Lee J Martin
Journal:  Pharmaceuticals (Basel)       Date:  2010

Review 3.  Synaptic dysfunction in genetic models of Parkinson's disease: a role for autophagy?

Authors:  Edward D Plowey; Charleen T Chu
Journal:  Neurobiol Dis       Date:  2010-10-20       Impact factor: 5.996

Review 4.  Biology of mitochondria in neurodegenerative diseases.

Authors:  Lee J Martin
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

Review 5.  Basal Forebrain Cholinergic Circuits and Signaling in Cognition and Cognitive Decline.

Authors:  Elizabeth C Ballinger; Mala Ananth; David A Talmage; Lorna W Role
Journal:  Neuron       Date:  2016-09-21       Impact factor: 17.173

6.  Alterations in corticostriatal synaptic plasticity in mice overexpressing human alpha-synuclein.

Authors:  J B Watson; A Hatami; H David; E Masliah; K Roberts; C E Evans; M S Levine
Journal:  Neuroscience       Date:  2009-03-17       Impact factor: 3.590

7.  Alpha-synuclein deficiency leads to increased glyoxalase I expression and glycation stress.

Authors:  Alexander Kurz; Naila Rabbani; Michael Walter; Michael Bonin; Paul Thornalley; Georg Auburger; Suzana Gispert
Journal:  Cell Mol Life Sci       Date:  2010-08-14       Impact factor: 9.261

8.  Impact of environmental thermal stimulation on activation of hypothalamic neuronal nitric oxide synthase during the prenatal ontogenesis in Muscovy ducks.

Authors:  Valery Dunai; Barbara Tzschentke
Journal:  ScientificWorldJournal       Date:  2012-04-19

9.  Role of phosphodiesterase 5 in synaptic plasticity and memory.

Authors:  Daniela Puzzo; Salvatore Sapienza; Ottavio Arancio; Agostino Palmeri
Journal:  Neuropsychiatr Dis Treat       Date:  2008-04       Impact factor: 2.570

10.  High Throughput Sequencing Identifies MicroRNAs Mediating α-Synuclein Toxicity by Targeting Neuroactive-Ligand Receptor Interaction Pathway in Early Stage of Drosophila Parkinson's Disease Model.

Authors:  Yan Kong; Xijun Liang; Lin Liu; Dongdong Zhang; Chao Wan; Zhenji Gan; Liudi Yuan
Journal:  PLoS One       Date:  2015-09-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.